Akura Medical, A New Shifamed Portfolio Company, Closes $25M In An Oversubscribed Series A1 Financing
Akura Medical, A New Shifamed Portfolio Company, Closes $25M In An Oversubscribed Series A1 Financing
01/10/22, 8:01 AM
Location
campbellMoney raised
$25 million
Industry
financial services
mobile
Round Type
series a
Akura Medical, Inc., a Shifamed portfolio company, announced today the closing of its $25M Series A1 financing, which will be used to support the development of its next-generation thrombectomy device. The financing was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), PA MedTech VC Fund and Shifamed angel investors.
Company Info
Location
campbell, kentucky, united states
Additional Info
Akura Medical, a privately held portfolio company of Shifamed LLC, is developing a next generation thrombectomy device that aims to simplify thrombectomy through an easy to use, single pass procedure that efficiently removes blood clots. To learn more about Akura Medical, please visit www.akuramed.com.